InvestorsHub Logo
Followers 45
Posts 3345
Boards Moderated 0
Alias Born 02/08/2014

Re: jour_trader post# 403656

Sunday, 07/14/2024 12:55:34 AM

Sunday, July 14, 2024 12:55:34 AM

Post# of 428351
Thank you for sharing what you learned. It sounds like the needle movers weren't mentioned (unless I missed that in your summary). Perhaps doing that is considered too speculative. If the person or AI bot examined the 10K or one of the last few 10Qs they/it should know about these. The 70MN rev target was only mentioned in the CC transcript (not 10K) so we know they/it included the CC in its analysis.

Did it provide an estimate of the market for the three recently acquired ANDAs? I would think an analyst would have access to that information and knowing the market share of these new drugs is key to understanding their impact on share price. So that information should be included in an article describing the rational for an outperform rating.

Anyway, it sounded like an ok assessment that points out a few, but not all of the catalysts that are likely to propel Elite's stock higher in the next 6 to 9 months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News